Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Bayer CEO Sees $15 Billion Market for Xarelto, New Blood Thinners
Sept. 16, 2010
The market for new blood thinners including Johnson & Johnson and Bayer AG’s Xarelto could eventually reach $12 billion to $15 billion a year, Bayer Chief Executive Officer Werner Wenning said.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing